IDO1 and neoplasm: Based on the role of pyroptosis and IDO in tumor immune response, researchers hypothesized that the combination of NO-mediated pyrokinesis inducers with IDO inhibition-based immunotherapy is a promising approach for the construction of novel nanomedicines.